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Activation of native TRPC1/C5/C6 channels by endothelin-1
is mediated by both PIP3 and PIP2 in rabbit coronary artery
myocytes
Sohag N. Saleh, Anthony P. Albert and William A. Large
Ion Channels and Cell Signalling Research Centre, Division of Basic Medical Sciences, St George’s, University of London, Cranmer Terrace, London
SW17 0RE, UK
We investigate activation mechanisms of native TRPC1/C5/C6 channels (termed TRPC1
channels) by stimulation of endothelin-1 (ET-1) receptor subtypes in freshly dispersed rabbit
coronary artery myocytes using single channel recording and immunoprecipitation techniques.
ET-1 evoked non-selective cation channel currents with a unitary conductance of 2.6 pS which
were not inhibited by either ETA or ETB receptor antagonists, respectively BQ-123 and BQ788,
when administered separately. However, in the presence of both antagonists, ET-1-evoked
channel activity was abolished indicating that both ETA and ETB receptor stimulation activate
this conductance. Stimulation of both ETA and ETB receptors evoked channel activity which
was inhibited by the protein kinase C (PKC) inhibitor chelerythrine and by anti-TRPC1 anti-
bodies indicating that activation of both receptor subtypes causes TRPC1 channel activation by
a PKC-dependent mechanism. ETA receptor-mediated TRPC1 channel activity was selectively
inhibited by phosphoinositol-3-kinase (PI-3-kinase) inhibitors wortmannin (50 nm) and PI-828
and by antibodies raised against phosphoinositol-3,4,5-trisphosphate (PIP3), the product
of PI-3-kinase-mediated phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2).
Moreover, exogenous application of diC8-PIP3 stimulated PKC-dependent TRPC1 channel
activity. These results indicate that stimulation of ETA receptors evokes PKC-dependent
TRPC1 channel activity through activation of PI-3-kinase and generation of PIP3. In contrast,
ETB receptor-mediated TRPC1 channel activity was inhibited by the PI-phospholipase C
(PI-PLC) inhibitor U73122. 1-Oleoyl-2-acetyl-sn-glycerol (OAG), an analogue of diacylglycerol
(DAG), which is a product of PI-PLC, also activated PKC-dependent TRPC1 channel activity.
OAG-induced TRPC1 channel activity was inhibited by anti-phosphoinositol-4,5-bisphosphate
(PIP2) antibodies and high concentrations of wortmannin (20μm) which depleted tissue
PIP2 levels. In addition exogenous application of diC8-PIP2 activated PKC-dependent TRPC1
channel activity. These data indicate that stimulation of ETB receptors evokes PKC-dependent
TRPC1 activity through PI-PLC-mediated generation of DAG and requires a permissive
role of PIP2. In conclusion, we provide the first evidence that stimulation of ETA and ETB
receptors activate native PKC-dependent TRPC1 channels through two distinct phospholipids
pathways involving a novel action of PIP3, in addition to PIP2, in rabbit coronary artery
myocytes.
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Introduction
Endothelin-1 (ET-1) produces vasoconstriction by a
direct action on vascular smooth muscle cells through
stimulation of predominantly ETA receptors, although
ETB receptors are involved in some vascular beds (Sumner
et al. 1992; Davenport & Battistini, 2002). Moreover in the
coronary circulation activation of ET-1 receptors has been
linked to exaggerated constriction of human coronary
artery leading to myocardial ischaemia in coronary artery
disease (Schiffrin & Touyz, 1998; Kinlay et al. 2001).
ET-1-induced vasoconstriction is mediated
almost entirely by influx of Ca2+ ions through
voltage-independent ion channels (see Miwa et al.
2005). These data suggest that ET-1 contracts vascular
smoothmuscle by opening Ca2+-permeable non-selective
cation channels. Consistent with this notion we
demonstrated that ET-1 activates two distinct types of
canonical transient receptor potential (TRPC) channels
in freshly dispersed rabbit coronary myocytes. At low
concentrations (1–10 nM) ET-1 activates a non-selective
cation channel with four subconductance states of
between 16 and 68 pS (Peppiatt-Wildman et al. 2007).
These responses were mediated mainly by ETA receptors
andweremimicked by the diacylglycerol (DAG) analogue,
1-oleoyl-2-acetyl-sn-glycerol (OAG) via a protein kinase
C (PKC)-independent mechanism. Evidence indicated
that this cation channel protein is a heteromeric structure
consisting of TRPC3/TRPC7 subunits (Peppiatt-Wildman
et al. 2007).
In contrast at higher concentrations (100 nM) ET-1
evokes a PKC-dependent 2.6 pS Ca2+-permeable cation
channel which has characteristics of a heteromeric
TRPC1/TRPC5/TRPC6 structure (subsequently referred
to as TRPC1 channels, Saleh et al. 2008). With this
concentration of ET-1 the TRPC3/TRPC7 conductance
is not observed.
In the present study we have investigated the trans-
duction mechanisms linking ET-1 receptors to native
TRPC1 ion channels described above in coronary artery
myocytes. The results demonstrate that TRPC1 channels
may be activated by stimulation of either ETA or ETB
receptors using two distinct phosphoinositide signalling
pathways involving respectively phosphatidylinositol
3,4,5-trisphosphate (PIP3) and phosphatidylinositol
4,5-bisphosphate (PIP2). This is the first demonstration
that PIP3, in addition to PIP2, activates native TRPC1
channels.
Methods
Cell isolation
New Zealand White rabbits (2–3 kg) were killed using
I.V. sodium pentobarbitone (120mg kg−1, in accordance
with the UK Animals (Scientific Procedures Act) 1986).
Experimental methods were carried out as specified by St
George’s animal welfare committee and according to the
policies of The Journal of Physiology (Drummond, 2009).
Right and left anterior descending coronary arteries were
dissected free from fat and connective tissue in physio-
logical salt solution containing (mM): NaCl (126), KCl (6),
glucose (10), Hepes (11), MgCl2 (1.2) and CaCl2 (1.5),
with pH adjusted to 7.2 with 10 M NaOH. An incision
was made along the longitudinal axis of the blood vessels
and the exposed endothelium was gently removed using
a cotton bud. Enzymatic digestion and smooth muscle
cell isolation were subsequently carried using methods
previously described (Saleh et al. 2006).
Electrophysiology
Single channel currents were recorded in voltage-clamp
mode using cell-attached and inside-out patch
configurations (Hamill et al. 1981) with a HEKA
EPC 8 patch-clamp amplifier (HEKA Elektronik,
Lambrecht/Pfalz, Germany) at room temperature
(20–23◦C). Patch pipettes were manufactured from
borosilicate glass to produce pipettes with resistances of
6–10M for isolated patch recording when filled with
patch pipette solution. To reduce ‘line’ noise the recording
chamber (vol. ca 150–200μl) was perfused using two
20ml syringes, one filled with external solution and the
other used to drain the chamber, in a ‘push and pull’
technique. The external solution could be exchanged
twice within 30 s. In cell-attached patch recording, the
membrane potential was set to ∼0mV using a high
KCl bathing solution (see below). In both cell-attached
and inside-out patch recordings, +70mV was applied
to the patch and held at this level except for measuring
current–voltage (I–V ) relationships when the applied
patch voltage wasmanually altered between+120mV and
−50mV. According to convention in the text membrane
potential is given with respect to the internal potential and
thus, the restingholdingpotential is referred to as−70mV.
Single channel currents were initially recorded onto
digital audiotape (DAT) using a Sony PCM-R300
digital tape-recorder (BioLogic Science Instruments,
Claix, France) at a bandwidth of 5 kHz (HEKA EPC 8
patch-clamp amplifier) and a sample rate of 48 kHz. For
off-line analysis, single channel currents were filtered at
100 Hz (see below, −3 db, low pass 8-pole Bessel filter,
model LP02, Frequency Devices Inc., Ottawa, IL, USA)
and acquired using a Digidata 1322A and pCLAMP 9.0 at
a sampling rate of 1 kHz. Data were captured with a Dell
Dimension 5150 personal computer.
Single channel current amplitudes were calculated from
idealised traces of at least 60 s in duration using the
50% threshold method and analysed using pCLAMP
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v.9.0 software with events lasting for <6.664ms (2 ×
rise time for a 100 Hz, −3 db, low pass filter) being
excluded from analysis. Single channel current amplitude
histograms were plotted and fitted with Gaussian curves
with the peak of these curves determining the unitary
amplitude of the single channel currents.Openprobability
(NPo) was calculated automatically using pCLAMP 9.
Figure preparation was carried out using Origin 6.0
software (OriginLab Corp., Northampton, MA, USA)
where inward single channel openings are shown as down-
ward deflections.
Solutions and drugs
In cell-attached patch experiments the membrane
potential was set to approximately 0 mV by perfusing
cells in a KCl external solution containing (mM): KCl
(126), CaCl2 (1.5), Hepes (10) and glucose (11), pH
adjusted to 7.2 with 10 M KOH. Nicardipine (5μM) was
also included to prevent smooth muscle cell contraction
by blocking Ca2+ entry through voltage-dependent
Ca2+ channels. The bathing solution used in inside-out
experiments (intracellular solution) contained (mM):CsCl
(18), caesium aspartate (108), MgCl2 (1.2), Hepes (10),
glucose (11), BAPTA (1), CaCl2 (0.48, free internal Ca2+
concentration approximately 100 nM as calculated using
EQCAL software), Na2ATP (1) and NaGTP (0.2), pH 7.2
with Tris.
The patch pipette solution used for both cell-attached
and inside-out patch recording (extracellular solution)
was K+ free and contained (mM): NaCl (126), CaCl2 (1.5),
Hepes (10), glucose (11), TEA (10), 4-AP (5), iberiotoxin
(0.0002), 4,4′-diisothiocyanatostilbene-2,2′-disulfonic
acid (DIDS) (0.1), niflumic acid (0.1) and nicardipine
(0.005), pH adjusted to 7.2 with NaOH. Under these
conditions voltage-dependent Ca2+ currents, K+
currents, swell-activated Cl− currents and Ca2+-activated
Cl− conductances are abolished and non-selective cation
currents could be recorded in isolation.
Anti-TRPC1 (which detects TRPC1 proteins with a
predicted molecular mass of ∼100 kDa) and anti-PIP2
antibodies (which detect liposome complex of PIP2
molecules with a predicted molecular mass of ∼75 kDa,
see manufacturer’s data sheet and Fukami et al. 1988)
were from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA, USA) and alomone labs (Israel), anti-PIP3 antibodies
were fromMBL (Japan) and anti-β-actin antibodies were
from Sigma (UK). Pre-incubation of anti-TRPC1 anti-
bodies with its antigenic peptide was carried out in a
1 : 2 ratio for at least 2 h in control experiments. Unless
otherwise stated all other drugs were purchased from
Calbiochem (UK), Sigma (UK) or Tocris (UK) and agents
were dissolved in distilled H2O or DMSO (0.1%). DMSO
alone had no effect on channel activity. The values are
the mean of n cells± S.E.M. Statistical analysis was carried
out using paired (comparing effects of agents on the same
cell) or unpaired (comparing effects of agents between
cells) Students’ t test with the level of significance set at
P < 0.05.
Immunoprecipitation and Western blotting
Dissected tissues were flash frozen and stored in 10mM
TRIS-HCl (pH 7.4) at −80◦C for subsequent use.
Tissues were defrosted and mechanically disrupted with
an Ultraturrax homogeniser and further disrupted by
sonication on ice for at least 2 h. Tissues were subsequently
centrifuged at 25 000 g for 30min at 4◦C and the super-
natant was discarded. The total cell lysate (TCL) was
then collected by centrifugation at 11 200 g for 10min in
10mgml−1 RIPA lysis buffer (Santa Cruz Biotechnology),
supplemented with protease inhibitors. Protein content
was quantified using the Bio-Rad protein dye reagent
(Bradford method). TCL was retained on ice for
subsequent experimental procedures including dot-blots
and immunoprecipitation. Dot-blots were carried out by
‘spotting’ 2–5μl of TCL on prepared immobilon-p poly-
vinylidene difluoride (PVDF) membranes. Membranes
were allowed to dry prior to detection using conventional
Western blotting techniques (see later). The immuno-
precipitation protocol was carried out using the Millipore
Catch and Release
R©
kit, where spin columns were loaded
with 500μg of TCL and 2–6μg of antibody and immuno-
precipitated for 2 h at room temperature.
Immunoprecipitated samples were eluted with
Laemmli sample buffer and incubated at 60◦C for
5min. One-dimensional protein gel electrophoresis was
performed in 4–12% Bis-Tris Gels in a Novex mini-gel
system (Invitrogen) with 10–20μg of total protein
loaded in each lane. Separated proteins were trans-
ferred onto PVDF membranes using the Invitrogen iBlot
apparatus. Western blotting was subsequently carried out
onmembraneswhichwere incubatedwith the appropriate
primary antibody for 2 h at room temperature. Where
possible, alternative antibodies raised against different
epitopes were used for immunoprecipitation andWestern
blot analysis. Following antibody removal membranes
were washed for 2 h with milk/phosphate-buffered saline
with Tween 20 (PBST) and were subsequently incubated
with horseradish peroxidase-conjugated secondary anti-
body diluted 1 : 1000–5000 in milk/PBST. Membranes
were then washed 3 times for 15min in PBST, followed
by a final wash in PBS before being treated with ECL
chemiluminescence reagents (Pierce Biotechnology, Inc.,
Rockford, IL,USA) for 1min andexposed tophotographic
films. Data shown represents n values of at least three
separate experiments.
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Results
Stimulation of ETA and ETB receptors activate 2–3 pS
cation channel currents in rabbit coronary artery
myocytes
In initial experiments we investigated the identity of the
ET-1 receptor subtype involved in activating native 2–3 pS
cation channel currents. For these experiments 100 nM
ET-1 was used since at these concentrations ET-1 does
not activate the TRPC3/C7 conductance expressed in
this preparation (see Peppiatt-Wildman et al. 2007 and
Introduction) and the 2–3 pS conductance is recorded
in isolation. Both ETA and ETB G-protein-coupled
receptors are expressed in vascular smooth muscle (see
Miwa et al. 2005) and therefore we studied the effect
of selective concentrations of ETA and ETB receptor
antagonists, respectively BQ-123 andBQ-788 (Davenport,
2002), on ET-1-induced native 2–3 pS channel activity
in cell-attached patches from freshly dispersed coronary
artery myocytes.
Figure 1A, E and F shows that bath application of
100 nM ET-1 activated cation channel activity at −70mV
which had a mean peak open probability (NPo) of
0.25± 0.07 (n = 10) and was composed of channel
openings with a unitary conductance of 2.6 pS and a
reversal potential (Er) of about 0mV.These responseswere
seen in approximately 90% of patches tested. Figure 1Ab
illustrates that the channel current amplitude histogramof
Figure 1. Stimulation of ETA and ETB receptors activates 2–3 pS cation channel currents in cell-attached
patches from freshly dispersed coronary artery myocytes
Aa, bath application of 100 nM ET-1 induced cation channel activity at an applied patch voltage of +70 mV.
According to convention we will refer to this as −70 mV membrane potential throughout the text (see Methods).
Ab, amplitude histogram of channel currents shown in Aa could be fitted with the sum of four Gaussian curves
indicating 1 closed and 3 multiple open levels inferring that the patch contained at least 3 channels. B and C, ET-1
evoked cation channel activity in the presence of respectively either the ETA receptor antagonist 100 nM BQ-123
or the ETB receptor antagonist 100 nM BQ-788. D and F, ET-1-induced cation channel activity was blocked in the
presence of a mixture of 100 nM BQ-123 and 100 nv BQ-788 at −70 mV. E, I–V relationship of cation channel
currents evoked by ET-1 (open circles), ET-1 in the presence of BQ-123 (open squares) and ET-1 in the presence
of BQ-788 (filled squares) showing that they all had a unitary conductance of 2.6 pS and Er of about 0 mV. Each
point represents at least n = 6. F, mean data showing neither BQ-123 nor BQ-788 inhibited ET-1-evoked channel
activity when applied separately. However when the antagonists were added together ET-1-evoked cation channel
activity was abolished. Each value is the mean of 10 patches.
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ET-1-evoked channel activity shown in Fig. 1Aa could be
fitted by the sum of four Gaussian curves representing one
closed and three open levels of the same conductance,
i.e. there were at least three channels in the patch.
Figure 1B and F shows that pre-treatment with the ETA
receptor antagonist 100 nMBQ-123 for 5minhadno effect
on ET-1-induced channel activity (n = 10). In addition,
Fig. 1C and F shows that pre-treatment with the ETB
receptor antagonist 100 nM BQ-788 for 5min also had no
effect on ET-1-evoked channel activity (n = 10). Figure 1E
shows that ET-1 activated the same 2.6 pS channel
currents in the presence of either BQ-123 or BQ-788
and in the absence of receptor antagonists. However,
Fig. 1D and F illustrates that that pre-treatment with
co-applicationofboth100 nMBQ-123and100 nMBQ-788
for 5 min almost completely abolished ET-1-induced
channel activity (n = 8, P < 0.001).
These data showing that both ETA and ETB receptor
antagonists must be present to block channel activity
by ET-1 indicate that stimulation of both ETA and ETB
receptors can lead to channel opening.
Stimulation of ETA and ETB receptors activates TRPC1
channel currents through a PKC-dependent
mechanism
Previously we have shown that ET-1 and agents that
deplete internal Ca2+ stores, cyclopiazonic acid (CPA) and
BAPTA-AM, evoke native 2.6 pS TRPC1 channel currents
in coronary artery myocytes which are inhibited by PKC
inhibitors (Saleh et al. 2008; Albert et al. 2009). Therefore
we investigated the role of PKC and TRPC1 subunits in
mediating both ETA and ETB receptor-mediated channel
activity. In these experiments we bath applied ET-1 in the
presence of either BQ-788 or BQ-123 to evoke respectively
ETA or ETB receptor-coupled pathways in cell-attached
patches.
Figure 2A shows that the mean NPo of ETA
receptor-mediated channel activity, activated by 100 nM
ET-1 in the presence of 100 nM BQ-788, was significantly
reduced from 0.37± 0.04 to 0.06± 0.01 (83± 5%
inhibition, n = 6, P < 0.01) by the PKC inhibitor
chelerythrine (3μM). Figure 2B shows that the mean
Figure 2. Stimulation of ETA and ETB receptors activates native TRPC1 channel currents via a
PKC-dependent mechanism
A and B, stimulation of ETA (100 nM BQ-788 present) or ETB receptors (100 nM BQ-123 present) with 100 nM ET-1
evoked channel activity that was inhibited by co-application of 3 μM chelerythrine in cell-attached patches held
at −70 mV. C and D, stimulation of respectively ETA and ETB receptors evoked channel activity initially induced
in cell-attached patches which was inhibited by application of 1 : 200 dilution of anti-TRPC1 antibodies following
excision of patches into the inside-out configuration (i/o). E and F, following pre-incubation of anti-TRPC1 anti-
bodies (1 : 200) with its antigenic peptide (1 : 100, AgP) bath application of the complex had no effect on ETA
receptor-mediated or ETB receptor-mediated channel activity.
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NPo of ETB receptor-mediated channel activity, activated
by 100 nM ET-1 in the presence of 100 nM BQ-123,
was also significantly inhibited from 0.31± 0.08 to
0.05± 0.02 (84± 3% inhibition, n = 7, P < 0.01) by 3μM
chelerythrine.
Figure 2C illustrates that ETA receptor-mediated
channel activity in cell-attached patches was maintained
following excision into the inside-out configuration and
that bath application of anti-TRPC1 antibodies to the
cytosolic surface of these inside-out patches significantly
reducedmeanNPo of ETA receptor-mediated activity from
0.19± 0.03 to 0.01± 0.01 (95± 5% inhibition, n = 5,
P < 0.01). Moreover Fig. 2D shows that anti-TRPC1 anti-
bodies also significantly inhibited the mean NPo of ETB
receptor-mediated channel activity from 0.22± 0.08 to
0.03± 0.02 (87± 8% inhibition, n = 5, P < 0.01). In
control experiments, Fig. 2E and F show that following
pre-incubation with their antigenic peptide, anti-TRPC1
antibodies had no effect on ETA receptor-mediated
or ETB receptor-mediated channel activity (n = 4 for
each). Channel activity often recovered, at least partially,
following washout of anti-TRPC1 antibodies indicating
some degree of reversibility in the conditions used.
These data show that stimulation of both ETA and ETB
receptors activates TRPC1 channel currents through a
PKC-dependentmechanism in coronary arterymyocytes.
Distinct signalling pathways mediate ETA and ETB
receptor stimulation of TRPC1 channel activity
In the next series of experiments we investigated the
signalling pathways linking ETA and ETB receptors
to PKC-mediated opening of TRPC1 channels. ETA
and ETB G-protein-coupled receptors can be linked to
different phospholipases that generate the endogenous
PKC activator diacylglycerol (DAG, Ivey et al. 2008).
Therefore we investigated the effect of biochemically
characterised pharmacological inhibitors of endogenous
phospholipases on ETA and ETB receptor-mediated
TRPC1 channel activity in cell-attached patches.
Figure 3A shows that the phosphoinositol-
phospholipase C (PI-PLC) inhibitor U73122 (2μM)
significantly inhibited the mean NPo of ETB receptor-
mediated TRPC1 channel activity from 0.26± 0.05 to
0.04± 0.02 (89± 4% inhibition, n = 7, P < 0.01) whereas
Fig. 3B demonstrates that this PI-PLC inhibitor had no
effect on ETA receptor-mediated TRPC1 channel activity
(control mean NPo was 0.21± 0.06 and 0.18± 0.05
in U73122, n = 7). In addition, 2μM U73343, an
inactive analogue of U73122, had no effect on ETB
receptor-mediated TRPC1 channel activity (n = 4, data
not shown).
The above studies indicate that a PI-PLC-mediated
mechanism couples ETB receptors to TRPC1 channel
Figure 3. Stimulation of ETB, but not ETA, receptors activates TRPC1 channel currents via a PLC-mediated
transduction pathway in cell-attached patches
A, ETB receptor-mediated TRPC1 channel activity was inhibited by co-application of 2 μM U73122 at −70 mV. B,
ETA receptor-mediated TRPC1 channel activity was unaffected by co-application of 2 μM U73122. C, mean data
showing that ETA receptor-mediated TRPC1 channel activity (ET-1-evoked NPo in the presence of 100 nM BQ-788)
at −70 mV was also unaffected by co-application of inhibitors against different phospholipases and Rho kinase
(see text for details).
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stimulation but is unlikely to be involved in activating
native TRPC1 channels through stimulation of ETA
receptors. Therefore we investigated the effects of several
established inhibitors of other phospholipases that may be
involved in ETA receptor-mediated activation of TRPC1
channel currents. Figure 3C shows that pharmacological
inhibitors of phosphatidylcholine-PLC (PC-PLC, 100μM
D-609, n = 5), cytosolic and Ca2+-dependent and
-independent forms of phospholipase A2 (PLA2, 100μM
AACOCF3, n = 4 and 100μM PACOCF3, n = 4) and
phospholipase D (PLD, 100μM C2-ceramide, n = 6) had
no effect on ETA receptor-mediated TRPC1 channel
activity. Stimulation of ETA receptors has also been shown
to activate Rho kinase (Ivey et al. 2008) but Fig. 3C
shows that the Rho kinase inhibitors HA-110 (5μM,
n = 5) and Y27632 (1μM, n = 5) had no effect on ETA
receptor-mediated TRPC1 channel activity. These data
suggest that PC-PLC, PLA2, PLD and Rho kinase are also
not involved in TRPC1 channel activation initiated by ETA
receptor stimulation.
Previous studies have shown that stimulation of
ETA receptors can activate phosphoinositol-3-kinase
(PI-3-kinase), which phosphorylates PIP2 to form PIP3,
with the latter phospholipid capable of stimulating PKC
activity (see review by Ivey et al. 2008). Therefore
we investigated the role of a PI-3-kinase-mediated
mechanism on ETA and ETB receptor-mediated TRPC1
channel activity in cell-attached patches using selective
concentrations of wortmannin and a structurally different
compound, PI-828, which both inhibit PI-3-kinase.
Figure 4A shows that 50 nM wortmannin significantly
reduced mean NPo of ETA receptor-mediated TRPC1
channel activity from 0.23± 0.06 to 0.02± 0.01 (94± 4%
inhibition, n = 6, P < 0.01). In addition Fig. 4B shows
that 3μM PI-828 also significantly attenuated mean NPo
of ETA receptor-mediated TRPC1 channel activity from
0.14± 0.04 to 0.02 ± 0.01 (85± 5% inhibition, n = 5,
P < 0.01). Importantly, Fig. 4C and D illustrates that
50 nM wortmannin (control mean NPo of 0.18± 0.06
and 0.18± 0.07 in wortmannin, n = 6) and 3μM PI-828
(control mean NPo of 0.31± 0.11 and 0.24± 0.08 in
PI-828, n = 6) had no effect on ETB receptor-mediated
TRPC1 channel activity indicating that these reagents do
not have direct non-specific effects on TRPC1 channel
currents.
These results provide evidence that stimulation
of ETA and ETB receptors evokes TRPC1 channel
activity via different signal transduction mechanisms.
Stimulation of ETA receptors is coupled to TRPC1
channels via a PI-3-kinase-dependent pathway whereas a
PI-PLC-dependent pathway links ETB receptor-mediated
TRPC1 channel opening, and both these pathways are
likely to induce TRPC1 channel activity through a
PKC-dependent mechanism.
Figure 4. Stimulation of ETA receptors activates TRPC1 channel currents via a PI-3-kinase-mediated
pathway in cell-attached patches
A and B show that ETA receptor-mediated TRPC1 channel activity was inhibited by co-application of 50 nM
wortmannin or 3 μM PI-828, whereas C and D show that these compounds had no effect on ETB receptor-mediated
TRPC1 channel activity.
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Involvement of PIP3 in ETA receptor-mediated
activation of TRPC1 channel currents
The above results suggest that generationof PIP3 produced
from the action of PI-3-kinase on PIP2 is required
for ETA receptor-mediated TRPC1 channel stimulation.
Consequently we investigated if exogenous PIP3 directly
activates TRPC1 channel currents in coronary artery
myocytes.
Figure 5A and B shows that bath application of 3μM
diC8-PIP3, a water soluble form of PIP3, to the cyto-
solic surface of inside-out patches activated cation channel
activity with a mean NPo of 0.32± 0.06 (n = 11) and
a unitary conductance of 2.6 pS with an Er of about
0mV. The threshold concentration of diC8-PIP3 was
approximately 1μM and maximum channel activation
was obtained with 10–20μM diC8-PIP3 (data not
shown). Figure 5C and D also illustrates that mean
NPo of diC8-PIP3-evoked channel activity in inside-out
patches was significantly inhibited from 0.21± 0.09
to 0.02± 0.02 (94± 4% inhibition, n = 5, P < 0.01)
by co-application with 3μM chelerythrine and from
0.28± 0.05 to 0.03± 0.02 (84± 7% inhibition, n = 5,
P < 0.01) with anti-TRPC1 antibodies.
The role of endogenous PIP3 in ETA receptor-mediated
stimulation of TRPC1 channel activity was investigated
using an anti-PIP3 antibody. Figure 5E shows that the
mean NPo of ETA receptor-mediated TRPC1 channel
stimulation, initially activated in cell-attached patches
in the presence of the ETB receptor antagonist BQ-788,
was significantly reduced from 0.25± 0.07 to 0.01± 0.01
(97± 1% inhibition, n = 6, P < 0.01) by bath application
of an anti-PIP3 antibody to the cytosolic surface of the
patches. In contrast, Fig. 5F illustrates that an anti-PIP3
antibody had no effect on ETB receptor-mediated TRPC1
channel activity (control mean NPo from 0.48± 0.08 to
0.51± 0.11 in anti-PIP3 antibody, n = 6).
These data clearly show that exogenous PIP3 and
ET-1 activate the same PKC-dependent TRPC1 channel
currents and also indicate that endogenous PIP3 mediates
activation of TRPC1 channel currents by ETA receptor
stimulation.
Involvement of PIP2 in ETB receptor-mediated
activation of TRPC1 channel currents
The above results indicate that ETB receptor-mediated
TRPC1 channel activity is coupled to a PI-PLC pathway
and to stimulation of PKC (see Figs 2 and 3). Previous
work suggests that this biochemical cascade is likely to
involve generation of DAG, through hydrolysis of PIP2
Figure 5. PIP3 activates TRPC1 channel currents via a PKC-dependent mechanism
A, bath application of 3 μM diC8-PIP3 activates cation channel activity in an inside-out patch at −70 mV. B,
current–voltage relation of diC8-PIP3-evoked cation channel activity yielded a unitary conductance of 2.6 pS and
an Er of about 0 mV. Each point was at least n = 4. C and D, respectively 3 μM chelerythrine and 1 : 200 dilution
of anti-TRPC1 antibodies inhibited diC8-PIP3-induced channel activity in inside-out patches at −70 mV. E and F,
co-application of 1 : 200 dilution of anti-PIP3 antibodies reduced ETA receptor-mediated TRPC1 channel activity
(E) but had no effect on ETB receptor-mediated TRPC1 channel activity (F).
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by PI-PLC, since 1-oleoyl-2-acetyl-sn-glycerol (OAG), a
cell-permeant DAG analogue, activates TRPC1 channel
activity through a PKC-dependent mechanism in rabbit
mesenteric artery, portal vein and also coronary artery
(see Albert & Large, 2002; Saleh et al. 2006, 2008).
Moreover, our recent findings extended this hypothesis by
proposing an obligatory role for PIP2 in PKC-dependent
activation of TRPC1 channels in portal vein smooth
muscle cells (Saleh et al. 2009) and therefore we
investigated the effects of PIP2 in coronary artery
myocytes.
Bath application of 10μM diC8-PIP2 to inside-out
patches induced cation channel activity which had a
mean NPo of 0.34± 0.11 at −70mV (n = 11) and a
unitary conductance of 2.6 pS and an Er of about
0mV (Fig. 6Aa and b). In addition, the mean NPo
of diC8-PIP2-evoked channel activity was significantly
reduced by co-application of anti-TRPC1 antibodies
(from 0.24± 0.08 to 0.02± 0.01, 88± 6% inhibition,
n = 5, P < 0.01, Fig. 6B) and by 3μM chelerythrine (from
0.31± 0.08 to 0.05± 0.03, 97± 6% inhibition, n = 6,
P < 0.01, Fig. 6C). These data provide evidence that
exogenous PIP2 activates TRPC1 channel currents via a
PKC-dependent mechanism.
OAG-evoked channel activity was significantly
inhibited by anti-TRPC1 antibodies (Fig. 6D, mean NPo
from 0.23± 0.08 to 0.03± 0.01, 87± 1% inhibition,
n = 4, P < 0.01) and by anti-PIP2 antibodies (Fig. 6E,
mean NPo from 0.32± 0.06 to 0.01± 0.01, 97± 1%
inhibition, n = 6, P < 0.01) in inside-out patches.
Figure 6F also shows that when tissues were pre-treated
with 20μM wortmannin for 30min to deplete tissue
PIP2 levels (see Fig. 7) OAG did not evoke TRPC1
channel activity in cell-attached patches (mean NPo of
0.01± 0.01, n = 6). These results suggest that endogenous
PIP2 has an obligatory role for OAG-evoked TRPC1
channel activation.
These studies demonstrate that stimulation of ETB
receptors induces TRPC1 channel activation through
stimulation of PI-PLC to generate DAG which activates
PKC leading to channel opening through a mechanism
involving endogenous PIP2.
Figure 6. Obligatory role of PIP2 in mediating OAG-induced TRPC1 channel activity via a PKC-dependent
mechanism
Aa and b, bath application of 10 μM diC8-PIP2 activates cation channel activity in inside-out patches at −70 mV
which has a unitary conductance of 2.6 pS and a Er of about 0 mV. B and C, diC8-PIP2-evoked channel activity is
inhibited by 1 : 200 anti-TRPC1 antibodies (B) and also by 3 μM chelerythrine (C). D and E, OAG-induced channel
activity is inhibited by 1 : 200 anti-TRPC1 antibodies (D) and also by 1 : 200 anti-PIP2 antibodies (E) in inside-out
patches held at −70 mV. F, pre-treatment with 20 μM wortmannin for 30 min prevented activation of TRPC1
activity by OAG in a cell-attached patches at −70 mV.
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PIP3 evokes TRPC1 channel activity independently
of PIP2
The present work shows that stimulation of ETA receptors
activates TRPC1 activity through a PI-3-kinase-mediated
pathway involving PIP3 (see Figs 4 and 5). Moreover
we demonstrate that exogenous diC8-PIP3 evokes
PKC-dependent TRPC1 channel activity (see Fig. 5). In
contrast, our data indicate that activation of TRPC1
channels by stimulation of ETB receptors involves a
permissive role for PIP2. In a previous reportwe stated that
PIP2 had an obligatory role for TRPC1 channel activation
in rabbit portal veinmyocytes (Saleh et al.2009).Therefore
we investigated whether endogenous PIP2 was necessary
for activation of TRPC1 channels by PIP3 in coronary
artery smooth muscle cells.
Figure 7A shows that following pre-treatment of
myocytes with 20μM wortmannin for 30min to deplete
PIP2 levels (see Fig. 5Ca) bath application of 3μM
diC8-PIP3 activated TRPC1 channel activity with a mean
peak NPo value of 0.31± 0.05 (n = 6) in inside-out
patches, which is similar to control values of channel
activity induced by 3μM PIP3 in the absence of
wortmannin (see above and Fig. 7Aa). Figure 7B shows
that anti-PIP2 antibodies had no effect on PIP3-induced
TRPC1 channel activity in inside-out patches (control
mean NPo of 0.23± 0.06 and 0.24± 0.08 in the presence
of anti-PIP2 antibodies, n = 6). Both of these procedures
blocked OAG-evoked TRPC1 channel activity (cf. Fig. 6E
and F). In other experiments the anti-PIP2 antibody
reduced TRPC1 channel activation by both ETA and
ETB receptor stimulation (data not shown). This is pre-
dictable since PIP2 acts as a substrate for PIP3 generated by
PI-3-kinase (ETA pathway) andDAG produced by PI-PLC
(ETB pathway).
Therefore with regard to direct TRPC1 channel
activation endogenous PIP2 is not obligatory for TRPC1
channel activation by PIP3 (ETA receptor pathway) but
Figure 7. PIP3 activation of TRPC1 channel activity is independent of PIP2
A, diC8-PIP3-evoked TRPC1 channel activity in inside-out patches held at −70 mV was not inhibited
by pre-treatment with 20 μM wortmannin for 30 min. B, 1 : 200 anti-PIP2 antibodies did not inhibit
diC8-PIP3-mediated channel activation. Ca, co-immunoprecipitation experiment showing association between PIP2
and TRPC1 proteins at rest (Con) after immunoprecipitation with anti-TRPC1 antibodies and blotting with anti-PIP2
antibodies which was reduced following pre-treatment with 20 μM wortmannin (Wort). Cb, upper panel shows
co-immunoprecipitation experiment following immunoprecipitation with anti-PIP2 antibodies and blotting with
anti-TRPC1 antibodies illustrating that PIP2 association with TRPC1 proteins is unaltered following pre-treatment
with 100 nM ET-1 and stimulation of ETA (100 nM ET-1 + 100 nM BQ-788) or ETB (100 nM ET-1 + 100 nM BQ-123)
receptors. Lower panel shows a Western blot in which following preincubation with its antigenic peptide (AgP),
detection of TRPC1 protein with anti-TRPC1 antibodies was reduced. Ca and b also show that wortmannin and
antigenic peptide had no effect on expression of β-actin proteins. D, dot-blot showing the presence of PIP2 but not
PIP3 levels in tissue lysates at rest and the reduction of PIP2 levels and increase of PIP3 levels following stimulation
of ETA receptors.
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is necessary for OAG (DAG)-induced (ETB receptor
pathway) TRPC1 channel stimulation.
To further investigate the role of PIP2 and PIP3
in mediating ET-1-induced TRPC1 channel activation
we carried out co-immunoprecipitation and dot-blot
studies. Figure 7Ca illustrates a co-immunoprecipitation
experiment which shows that at rest PIP2 is associated
with TRPC1 proteins in coronary artery when tissue
lysates were immunoprecipitated with anti-TRPC1 anti-
bodies and then blotted with anti-PIP2 antibodies to
detect a predicted band of ∼75 kDa (see Methods). In
addition Fig. 7Ca shows that pre-treatment of coronary
arteries with 20μM wortmannin for 30min reduced PIP2
association with TRPC1 proteins whereas total β-actin
levels were not altered. The upper panel in Fig. 7Cb shows
that stimulation of ETA or ETB receptors did not alter
PIP2 associationwith TRPC1proteins following immuno-
precipitation with anti-PIP2 antibodies and blotting
with anti-TRPC1 antibodies to detect a predicted band
of ∼100 kDa (see Methods). The middle panel shows
a control experiment in which pre-incubation of the
anti-TRPC1 antibody with its antigenic peptide (AgP)
reduced the detection of the predicted band for TRPC1
proteins on a Western blot. The lower panel shows that
the antigenic peptide had no effect on the expression of
β-actin.
It was not possible to detect total PIP3 levels using
Western blotting or association between PIP3 and TRPC1
proteins using co-immunoprecipitation at rest or after
stimulation of ETA and ETB receptors. This is probably
due to resting and receptor-mediated generation of PIP3
levels being too small to resolve with the limited amounts
of available coronary artery tissue. Therefore wemeasured
PIP3 and PIP2 levels using tissue lysate and dot-blot
techniques with their respective antibodies. Figure 7D
illustrates that at rest total cell lysates from coronary
arteries contained detectable PIP2 but not PIP3 whereas
upon stimulation of ETA receptors (ET-1 in the pre-
sence of BQ-788) the levels of PIP2 were reduced and
generation of PIP3 was detected whereas levels of β-actin
were unaffected.
These data provide novel evidence that PIP3 can activate
TRPC1 channels independently of PIP2 in coronary artery
myocytes.
Discussion
The present work provides the first evidence that
stimulation of ETA and ETB receptors by ET-1
activates native TRPC1 channel currents in freshly
dispersed coronary artery myocytes by two distinct
parallel phosphoinositide signalling pathways. Evidence is
provided to show that stimulation of ETA receptors evokes
TRPC1 channel currents through PI-3-kinase-mediated
generation of PIP3 which leads to opening of TRPC1
channels, possibly by a direct action. In contrast ETB
receptors are coupled to PI-PLC and production of DAG
leading to PIP2-mediated TRPC1 channel activation.
Moreover it appears that PKC is involved in activation
of TRPC1 channel currents by both PIP3 and PIP2.
Previously we have shown a permissive role for PIP2 in
activating TRPC1 channels in rabbit portal vein myocytes
(Saleh et al. 2009) but this is the first demonstration
that PIP3 also activates native TRPC1 channel currents.
Furthermore, to our knowledge, this is the first evidence
that PI-3-kinase may be involved in activation of
TRPC1 channel. Importantly, this pathway involving
PI-3-kinase-mediated generation of PIP3 represents a
novel activation mechanism of TRPC channels.
ETA receptor transduction mechanism and activation
of TRPC1 channel currents
ETA receptor-mediated stimulation of TRPC1 channel
activity is blocked by PI-3-kinase inhibitors and by
an anti-PIP3 antibody which did not inhibit TRPC1
channel activation induced by ETB receptor stimulation.
Moreover exogenous PIP3 applied to inside-out patches
evoked cation channel currents with identical properties
to those stimulated by ET-1, i.e. native TRPC1 channels.
Importantly, PIP3-induced TRPC1 channel activation
did not require endogenous PIP2 since PIP3 readily
activated TRPC1 channel currents in tissues pre-treated
with high concentrations of wortmannin, which reduced
association of PIP2 with TRPC1. Moreover an anti-PIP2
antibody which blocked responses to OAG did not inhibit
PIP3-evoked TRPC1 channel activity. Thus generation of
PIP3 by stimulation of ETA receptors activates TRPC1
channels with PIP3 possibly being the activating ligand,
which represents a novel mechanism of ion channel
activation.
Stimulation of ETA receptors expressed in Chinese
hamster ovary cells has been shown to increase PI-3-kinase
activity and PIP3 formation which was inhibited by
low concentrations of wortmannin (Sugawara et al.
1996). Our data also show that ETA receptor stimulation
increases PIP3 production. In vascular smooth muscle
ET-1 receptor stimulation leads to activation of several
signalling pathways including PI-3-kinase (see review by
Boualleque et al. 2007) and this mechanism is involved
in vasoconstriction (Kawanabe et al. 2004). Previously
PIP3 has been shown to bind to expressed TRPC1 proteins
(Kwon et al. 2007) although another study suggested that
PIP3 did not activate expressed TRPC1 channels (Tseng
et al. 2004). However in the same work it was shown
that PIP3 producesmarked stimulation of TRPC6 channel
activity (Tseng et al. 2004). Previously we indicated that
the 2.6 pS ET-1-induced conductance in coronary artery
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myocytes may be a heteromeric channel consisting of
TRPC1, TRPC5 and TRPC6 subunits (Saleh et al. 2008).
Therefore it is possible that the heteromeric structure of
native TRPC1 channels is more sensitive to PIP3 then
heterologously expressed TRPC1 proteins or that PIP3
binds to proposedTRPC5 or TRPC6 subunits of the native
conductance in coronary artery myocytes.
The present work does not reveal how ETA receptors
are linked to PI-3-kinase in coronary arteries but in other
systems it has been shown, and is generally accepted, that
Gβγ subunits activate PI-3-kinase (see Clapham & Neer,
1997; Vanhaesebroeck et al. 1997).
ETB receptor transduction mechanism and activation
of TRPC1 channel currents
The present work shows that ETB receptor-induced
stimulation of TRPC1 channel activity was markedly
inhibited by the PI-PLC inhibitor U73122, which did
not effect ETA receptor-mediated activation of TRPC1
channel activity. In addition OAG, an analogue of DAG
which is a product of PI-PLC stimulation, induced TRPC1
channel activity which was also inhibited by an anti-PIP2
antibody. Moreover OAG did not evoke TRPC1 channel
activity in cells pre-treated with high concentrations of
wortmannin, which depleted tissue PIP2 levels. These
electrophysiological data are consistent with a pathway
in which ETB receptors are coupled to PI-PLC, which
generates DAG and subsequently induces PIP2-mediated
activation of TRPC1 channels.
Application of exogenous PIP2 evoked TRPC1 channel
currents and co-immunoprecipitation studies showed
that PIP2 co-associated with TRPC1 proteins in resting
and ET-1-stimulated tissues. This finding is similar to a
previous study in rabbit portal vein myocytes in which it
was concluded that PIP2 is tethered to TRPC1 proteins
at rest but PKC-mediated phosphorylation of TRPC1
proteins was necessary to cause channel opening (Saleh
et al. 2009, see Large et al. 2009 for more detail). We
propose that a similar mechanism may be important for
ETB receptor stimulation in coronary artery myocytes.
Therefore the present work shows that both PIP2 and
PIP3 can activate TRPC1 channels in coronary artery
myocytes and our evidence is that PIP3 is obligatory for
ETA receptor-mediated stimulation of TRPC1 channels
whereas PIP2 is necessary for ETB receptor-mediated
activation of the same ion channel.
An interesting observation is that ETA and ETB
receptor-mediated TRPC1 channel activity is not additive
and that antagonism of both ETA and ETB receptors
is required to block ET-1-induced activation of TRPC1
channels. This suggests that both pathways were equally
effective in activating TRPC1 channels with the conditions
used in our experiments and may indicate a safeguard
mechanism for channel activation. Moreover these data
indicate how two receptor subtypes converge onto the
same TRPC1 channel utilising different transduction
pathways.
Role of PKC in activation mechanism of native TRPC1
channels by ETA and ETB receptor stimulation
Stimulation of TRPC1 activity by both ETA and ETB
receptors in coronary artery myocytes was almost
abolished by the PKC inhibitor chelerythrine. In addition,
the responses of PIP3 and PIP2, the proposed mediators
of respectively ETA and ETB receptors stimulation, were
also blocked by chelerythrine. Therefore it is evident that
PKC plays a central role in the activation mechanism of
TRPC1 channels by ET-1. Previously we demonstrated in
rabbit portal veinmyocytes thatTRPC1 channel activation
by the sarcoplasmic reticulum Ca2+-ATPase inhibitor
cyclopiazonic acid (CPA), phorbol 12,13-dibutyrate
(PDBu), a PKC stimulant, and PIP2 was associated with
phosphorylation of TRPC1 proteins which was inhibited
by chelerythrine (Saleh et al. 2009). Ahmmed et al. (2004)
also demonstrated that PKC-evoked phosphorylation of
expressed TRPC1 channels regulated store-operated Ca2+
entry in culturedendothelial cells. Importantly, thepresent
work adds significant support for the postulated activation
mechanism of TRPC1 channels (see Large et al. 2009 for
fully explanation) by showing that PIP3, another notable
endogenousphospholipid, also acts as a stimulatory ligand
of TRPC1 channels and requires a PKC-dependent process
which is likely to involve phosphorylation of TRPC1
subunits. In future experiments it will be interesting to
investigate the molecular basis of PIP3/PIP2-mediated
activation mechanisms of native TRPC1 channels using
expressed heterotetrameric channels involving TRPC1
subunits.
It has been shown that PIP3 also activates some PKC
isoforms in vitro (Nakanishi et al. 1993). Therefore on
ETA receptor stimulation production of PIP3 is likely both
to activate PKC and also to activate TRPC1 channels,
which leads to opening of channels through a positive
feedback process in which increased PKC-dependent
phosphorylation of TRPC1 proteins results in greater
PIP3-mediated channel activity. A similar transduction
mechanism has been proposed to link expressed M2
muscarinic receptors to an endogenous chloride channel
in Xenopus oocytes (Wang et al. 1999).
The observation that bath application of ET-1 evoked
channel activity recorded in a cell-attached patch suggests
that important signalling molecule(s) outlined above
translocate from receptors stimulated outside the patch to
ion channels underneath the pipette tip. A characteristic
of native TRPC channels is that once these signalling
pathways are activated by bath applied agonists in
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the cell-attached configuration channel activity persists
after excision into the inside-out configuration. In this
configuration there is no agonist present and it is possible
that processes that normally inhibit channel activity are
lost (e.g. cytosolic factors) when the membrane patch is
excised.
Multiple transduction mechanisms and TRPC channels
in vascular smooth muscle
In cell lines, receptor-mediated activation of expressed
TRPC channels is generally shown to be via stimulation
of Gαq/11 and activation of PI-PLC (e.g. see Hardie, 2007),
but in vascular smooth muscle more diverse signalling
pathways are involved. Therefore α1-adrenoceptors and
angiotensin II (Ang II) receptors are coupled to TRPC6
channels via PI-PLC in respectively rabbit portal vein
and mesenteric artery myocytes (Helliwell & Large, 1997;
Inoue et al. 2001; Saleh et al. 2006). In contrast constitutive
TRPC3 channels in rabbit ear artery myocytes are coupled
to Gαi/o proteins linked PC-PLD-induced production of
DAG (Albert & Large, 2004; Albert et al. 2005, 2006).
The present work adds yet another signalling cascade for
TRPC channels in which ETA receptor stimulation causes
PI-3-kinase-mediated production of PIP3 to activate
TRPC1 channels.
Agents that deplete intracellular Ca2+ stores also
stimulate TRPC1 channel activity and therefore these
channels are often termed store-operated channels
(SOCs). The present results with ET-1 and previous work
with noradrenaline in portal vein (Albert & Large, 2002)
and Ang II in mesenteric artery (Saleh et al. 2006) indicate
that membrane-delimited lipid pathways induce TRPC1
channel activity in isolated patches. Consequently TRPC1
channels behave more as receptor-operated channels than
as SOCs according to their strict definition.
Phospholipids and TRPC channels
There is increasing evidence that phospholipids regulate
transient receptor potential channels including TRPC
channel subtypes in native vascular myocytes and in
expression systems (Hardie 2007; Rohacs, 2007; Voets
& Nilius, 2007; Nilius et al. 2008; Large et al. 2009).
Endogenous PIP2 inhibits the excitatory effects of DAG
on TRPC6 in mesenteric artery myocytes (Albert et al.
2008) and also inositol 1,4,5-trisphosphate potentiates
the excitatory effects of DAG on both native TRPC6 and
TRPC1 channels in rabbit portal vein myocytes (Albert &
Large, 2003; Liu et al. 2005; Saleh et al. 2008). PIP2 has also
been shown to have complex actions on expressed TRPC
conductances with this phospholipid increasing TRPC3,
TRPC6 and TRPC7 channel activity (Lemonnier et al.
2007), inhibiting TRPC4 whole-cell currents (Otsuguro
et al. 2008) and having both excitatory and inhibitory
effects on TRPC5 channel activity (Trebak et al. 2008).
There is little information on the action on PIP3 on TRPC
channels although this phospholipid has been shown
to increase expressed TRPC6-mediated Ca2+ entry in
HEK293 cells recorded with a Ca2+-sensitive dye (Tseng
et al. 2004). However the present data provide the first
direct evidence that PIP3 activates native TRPC channels
in any cell type.
Conclusion
This study demonstrates that ET-1 activates native TRPC1
channels in rabbit coronary artery myocytes using two
distinct phospholipid signalling pathways. The data show
that PIP3 and PIP2 mediate the responses to respectively
ETA and ETB receptor stimulation and facilitate opening
of native TRPC1 channels. This is the first demonstration
that PIP3 activates native TRPC1 channels in vascular
smooth muscle.
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